Clinical Trial Update: A Study of LY2951742 in Healthy Japanese and Caucasian Participants [Phase 1]

View source ↗

Summary

Phase 1 trial update for LY2951742 in healthy Japanese and Caucasian participants with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Drugs mentioned

• LY2951742

Snippet

Sponsor: Eli Lilly and Company | Conditions: Migraine Disorders | Phase 1 | Status: COMPLETED | Results posted: 2019-06-14